市场调查报告书
商品编码
1467756
2024-2032 年按产品类型、应用、最终用途、最终用户和地区分類的一次性生物加工市场报告Single-Use Bioprocessing Market Report by Product Type, Application, End-Use, End-User, and Region 2024-2032 |
IMARC Group年,全球一次性生物加工市场规模达到 161 亿美元。慢性病盛行率的不断上升、技术进步的不断进步以及药物和生物製剂批准数量的增加是推动市场发展的一些关键因素。
一次性生物加工技术旨在对一次性使用的生物製药产品进行过滤、储存、细胞培养、混合和纯化。它具有成本效益、节省时间,并提供灵活性和无麻烦的处置。与传统的生物处理相比,它透过消除复杂的步骤来帮助提高生产力,并降低个体之间交叉污染的风险。除此之外,与钢铁相比,它还利于减少能源、介质消耗和碳足迹,并提供永续的製造流程。它用于有效生产疫苗、植物细胞培养和单株抗体。由于它还减少了工作人员进行设定、验证和记录的时间,因此全球范围内对一次性生物加工技术的需求正在增加。
目前,全球大众中糖尿病、气喘、关节炎、癌症、高血压、心臟病、中风和慢性阻塞性肺病(COPD)等慢性病的盛行率不断上升,这是支持成长的关键因素之一市场的。除此之外,由于世界各地药品核准和生物製剂数量不断增加,对一次性生物加工的需求不断增长,这对市场产生了积极影响。此外,人们对高檔聚合物材料和塑胶复合材料製造的产品的偏好不断提高,因为它们具有增强的整体强度,为行业投资者提供了利润丰厚的成长机会。除此之外,一次性生物处理系统提供的各种好处,例如较低的劳动力、材料和投资成本,正在推动市场的成长。除此之外,各种技术进步的出现,例如人工智慧(AI)、机器学习(ML)和一次性生物处理中用于预测错误和提高准确性的巨量资料解决方案,正在推动市场的成长。此外,在製药过程中,一次性生物加工在培养基製备和生物製剂运输中的使用日益增多,这提供了良好的市场前景。与此一致的是,一次性生物加工的日益普及,因为与传统生物加工相比,它减少了二氧化碳(CO2)的量,正在推动市场的成长。此外,由于全球医疗保健设施的改善,一次性生物加工的就业不断增加,也促进了市场的成长。
The global single-use bioprocessing market size reached US$ 16.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.5 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032. The growing prevalence of chronic diseases, increasing technological advancements, and rising number of drug approvals and biologics represent some of the key factors driving the market.
Single-use bioprocessing technology is designed for filtration, storage, cell culture, mixing, and purification of biopharmaceutical products for one-time use. It is cost-effective, timesaving, and provides flexibility and hassle-free disposal. It assists in increasing productivity by eliminating complex steps and reduces the risks of cross-contamination among individuals as compared to traditional bioprocessing. Besides this, it is beneficial in reducing energy, media consumption, and carbon footprint and providing a sustainable manufacturing process as compared to steel. It is utilized for the effective production of vaccines, plant cell cultivation, and monoclonal antibodies. As it also reduces the time of staff members for set-up, validation, and documentation, the demand for single-use bioprocessing technology is increasing across the globe.
Presently, the rising prevalence of chronic diseases, such as diabetes, asthma, arthritis, cancer, hypertension, heart attack, stroke, and chronic obstructive pulmonary disease (COPD), among the masses across the globe represents one of the key factors supporting the growth of the market. Apart from this, the growing demand for single-use bioprocessing due to the increasing number of drug approvals and biologics around the world is positively influencing the market. Additionally, rising preferences of products manufactured from high-grade polymer materials and plastic composites, as they offer enhanced integral strength, is offering lucrative growth opportunities to industry investors. Besides this, various benefits offered by single-use bioprocessing systems, such as lower labor, material, and investment costs, are propelling the growth of the market. In addition to this, the emergence of various technological advancements, such as artificial intelligence (AI), machine learning (ML), and big data solutions in single-use bioprocessing for predicting errors and improving accuracy, is bolstering the growth of the market. Moreover, the growing utilization of single-use bioprocessing in media preparation and shipping of biologics while manufacturing pharmaceuticals is offering a favorable market outlook. In line with this, the rising adoption of single-use bioprocessing, as it reduces the amount of carbon dioxide (CO2) compared to traditional bioprocessing, is impelling the growth of the market. Furthermore, the increasing employment of single-use bioprocessing due to the improving healthcare facilities across the globe is contributing to the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single-use bioprocessing market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, application, end-use and, end-user.
Media Bags and Containers
Filtration Assemblies
Single-Use Bioreactors
Disposable Mixers
Others
The report has provided a detailed breakup and analysis of the single-use bioprocessing market based on the product type. This includes media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others. According to the report, media bags and containers represented the largest segment.
Filtration
Storage
Cell Culture
Mixing
Purification
A detailed breakup and analysis of the single-use bioprocessing market based on the application has also been provided in the report. This includes filtration, storage, cell culture, mixing, and purification. According to the report, filtration accounted for the largest market share.
Upstream
Fermentation
Downstream
A detailed breakup and analysis of the single-use bioprocessing market based on the end-use has also been provided in the report. This includes upstream, fermentation, and downstream. According to the report, upstream accounted for the largest market share.
Biopharmaceutical Manufacturers
Life Science R&D
Others
A detailed breakup and analysis of the single-use bioprocessing market based on the end-user has also been provided in the report. This includes biopharmaceutical manufacturers, life science R&D, and others. According to the report, biopharmaceutical manufacturers accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, and others); and the Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, and others). According to the report, North America (the United States and Canada) was the largest market for single-use bioprocessing. Some of the factors driving the North America single-use bioprocessing market included the presence of large-scale manufacturing units, rising geriatric population, increasing healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global single-use bioprocessing market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc., 3M Company, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.